Biohaven Pharmaceutical Holding Company Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
28.20
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
10
|
|
# Buys
|
5
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-1.55
|
-1.74
|
-0.19
|
-12.21%
|
|
2024-06-30
|
-1.70
|
-3.50
|
-1.80
|
-106.15%
|
|
2024-03-31
|
-1.57
|
-2.20
|
-0.63
|
-40.13%
|
|
2023-12-31
|
-1.41
|
-1.81
|
-0.40
|
-28.37%
|
|
2023-09-30
|
-1.34
|
-1.50
|
-0.16
|
-11.94%
|
|
2023-06-30
|
-1.21
|
-1.32
|
-0.11
|
-9.09%
|
|
2023-03-31
|
-1.41
|
-1.03
|
0.38
|
26.95%
|
|
2022-12-31
|
-1.22
|
-3.32
|
-2.10
|
-172.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-7.44
|
|
2023-12-31
|
-5.66
|
|
2022-12-31
|
-14.25
|
|
2021-12-31
|
-13.08
|
|
2020-12-31
|
-13.04
|
|
2019-12-31
|
-10.97
|
|
2018-12-31
|
-6.20
|
|
2017-12-31
|
-5.46
|
|
2016-12-31
|
0.00
|
|
1990-12-31
|
-4.67
|